Case study

Case study on puberty

A 4-year-old girl presents to the paediatric endocrine clinic with signs of pubertal development, including vaginal bleeding.
How would you diagnose and manage this patient?

Find out more ›

IMAGE 2021

Recording of the live session coming soon!
We are delighted to announce the Springer Healthcare IME virtual meeting, entitled Insights into MAnaging Growth for Endocrine Nurses (IMAGE). This is the 8^th IMAGE conference, which focuses on differences in sexual development, and puberty disorders and reproductive problems in adolescents and young adults.

Find out more ›

Expert Review

Identification of GH insensitivity among short children with normal GH secretion

Read the latest expert review presented by Helen Storr

Find out more ›

Open Access Article Now Available

Digital technologies to improve the precision of paediatric growth disorder diagnosis and management

View the article published in the Growth Hormone & IGF Research journal that summarises the webinar discussion on the role of digital health in growth disorders.

Read the Open Access Article Now

News

Levo-thyroxine dose may need more initial adjustment with solution than pills in congenital hypothyroidism

Children using an oral solution of levo-thyroxine for treatment of congenital hypothyroidism may require closer monitoring during the first few months than those using tablet formulations, say researchers.

‘No clear benefit’ for morning vs evening 21-OHD high-dose hydrocortisone timing

A study of children and adolescents with classic 21-hydroxylase deficiency has found no significant difference in outcomes when giving the highest hydrocortisone dose of the thrice-daily schedule in the morning or the evening.

Rare GNAS mutations may underpin severe obesity even in absence of pseudohypoparathyroidism

Researchers have identified pathogenic mutations in the gene encoding the stimulatory G-protein alpha subunit protein in children with severe obesity but few or no clinical signs of pseudohypoparathyroidism.

rhGH treatment has positive growth, body composition effects in Kabuki Syndrome

Recombinant human growth hormone appears to have a positive effect on growth in children with Kabuki Syndrome, shows an open-label study.

IMAGE

Every year, up to 50 paediatric endocrine nurses convene for 2 days to interact with their professional peers and hear about the latest advances in their therapy area, direct from the expert endocrinologists.

View all IMAGE content

Conference coverage

medwireNews attends conferences around the world, bringing you breaking research news and expert interviews. Click here to see our endocrinology conference coverage.

View all conference coverage